American Heart Association examines the challenges of cardiovascular disease and breast cancer
Full article: http://circ.ahajournals.org/content/137/8/e30.long
Current breast cancer treatments can negatively affect cardiovascular health. Recently, the American Heart Association released its first scientific statement on cardiovascular disease and breast cancer. This statement includes a comprehensive overview of the prevalence of both diseases, shared risk factors, cardiotoxic effects of therapy and the prevention and treatment of cardiovascular disease in breast cancer patients. (5/2/18)
Questions To Ask Your Health Care Provider
- What are the heart risks associated with my cancer therapy?
- I have a family history of heart disease, is there anything I can do to protect my heart during or after treatment?
- Is heart monitoring needed during or after my cancer treatment?
- Should I be followed by a cardiologist?
Open Clinical Trials
The following studies are looking at management of side effects:
- NCT04533763: Living WELL: A Web-Based Program for Ovarian Cancer Survivors. This studies a group-based and web-delivered tool for ovarian cancer survivors in increasing quality of life and decreasing stress, depressive mood, anxiety, and fatigue across a 12-month period.
- NCT05047926: Prehabilitation for Advanced Ovarian Cancer Patients. Prehabilitation may improve peri-operative outcomes in patients undergoing cancer surgery. This study will look at structured activity for women undergoing neoadjuvant chemotherapy to improve their physical state prior to surgical intervention and thus improve outcomes.
FORCE is a national nonprofit organization, established in 1999. Our mission is to improve the lives of individuals and families affected by adult hereditary cancers.